Khaliunaa Mashbaatar

Affiliations
  • National Centre for Communicable Diseases, Ulaanbaatar, Mongolia.

Publications (1)

Immunogenicity, safety, and reactogenicity of a half- versus full-dose BNT162b2 (Pfizer-BioNTech) booster following a two-dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac priming schedule in Mongolia: a randomised, controlled, non-inferiority trial.

The Lancet regional health. Western Pacific
Avec: Tsetsegsaikhan Batmunkh , Kerryn A Moore , Helen Thomson , Bolor Altangerel , Otgonjargal Amraa , Naranbaatar Avaa , Lkhagvagaram Batbayar , Khishigjargal Batsukh , Kathryn Bright , Tsogjargal Burentogtokh , Lien Anh Ha Do , Gantuya Dorj , John D Hart , Khulan Javkhlantugs , Sarantsetseg Jigjidsuren , Frances Justice , Shuo Li , Paul V Licciardi , Nadia Mazarakis , Eleanor F G Neal , Cattram Duong Nguyen , Batbayar Ochirbat , Bilegtsaikhan Tsolmon , Alimaa Tuya , Unursaikhan Surenjav , Claire von Mollendorf , Kim Mulholland

Réseau de co-auteurs

Tsetsegsaikhan Batmunkh 1 collaboration
Kerryn A Moore 1 collaboration
Helen Thomson 1 collaboration
Bolor Altangerel 1 collaboration
Otgonjargal Amraa 1 collaboration
Naranbaatar Avaa 1 collaboration
Lkhagvagaram Batbayar 1 collaboration
Khishigjargal Batsukh 1 collaboration
Kathryn Bright 1 collaboration
Tsogjargal Burentogtokh 1 collaboration
Lien Anh Ha Do 1 collaboration
Gantuya Dorj 1 collaboration
John D Hart 1 collaboration
Khulan Javkhlantugs 1 collaboration
Sarantsetseg Jigjidsuren 1 collaboration
Frances Justice 1 collaboration
Shuo Li 1 collaboration
Paul V Licciardi 1 collaboration
Nadia Mazarakis 1 collaboration
Eleanor F G Neal 1 collaboration
Cattram Duong Nguyen 1 collaboration
Batbayar Ochirbat 1 collaboration
Bilegtsaikhan Tsolmon 1 collaboration
Alimaa Tuya 1 collaboration
Unursaikhan Surenjav 1 collaboration
Claire von Mollendorf 1 collaboration
Kim Mulholland 1 collaboration